Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Autiero, Ida ^a   Costantini, Susan ^a,b   Colonna, Giovanni ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CROM (Oncology Research Centre of Mercogliano) Fiorentino Lo Vuolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE REGULATOR OF SIRT1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIRT1 PROTEIN, HUMAN; SIRTUIN; SIRTUIN 1; TRANSCRIPTION FACTOR;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DATABASE; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; ALLOSTERIC SITE; AMINO ACID SEQUENCE; COMPUTER SIMULATION; DATABASES, PROTEIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; SIRTUIN 1; SIRTUINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 77957655795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007350     Document Type: Article

References (60)

1. Huhtiniemi T, Wittekindt C, Laitinen T, Leppänen J, Salminen A, et al.(2006) Comparative and pharmacophore model for deacetylase SIRT1. J Comput Aided Mol Des 20: 589-99.
2. Kim EJ, Kho JH, Kang MR, Um SJ, (2007) Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28: 277-90.
3. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, et al.(2008) Phosphorylation regulates SIRT1 function. PLoS ONE 3: e4020.
4. Saunders LR, Verdin E, (2007) Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26: 5489-5504.
5. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, et al.(2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
6. Yang Y, Hou H, Haller EM, Nicosia SV, Bai W, (2005) Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J 24: 1021-1032.
7. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, et al.(2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118.
8. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, et al.(2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104: 14855-14860.
9. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, et al.(2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPARgamma. Nature 429: 771-776.
10. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I, (2008) SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 861-870.
11. Ghosh HS, Spencer JV, Ng B, McBurney MW, Robbins PD, (2007) Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription. Biochem J 408: 105-111.
12. Kaeberlein M, McVey M, Guarente L, (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570-80.
13. Wang Y, Oh SW, Deplancke B, Luo J, Walhout AJ, et al.(2006) C. elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF-16/FOXO. Mech Ageing Dev 127: 741-747.
14. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, et al.(2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686-689.
15. Yamamoto H, Schoonjans K, Auwerx J, (2007) Sirtuin functions in health and disease. Mol Endocrinol 21: 1745-1755.
16. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, et al.(2007) Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med 39: 335-345.
17. Haigis MC, Guarente LP, (2006) Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921.
18. Hollander P, (2007) Diabetes Spectrum 20: 159.
19. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, et al.(2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-6.
20. Bemis JE, Vu CB, Xie R, Nunes JJ, Ng PY, et al.(2009) Discovery of oxazolo4,5-b.pyridines and related heterocyclic analogs as novel SIRT1 activators. Bioorg Med Chem Lett 19: 2350-3.
21. Zhao K, Harshaw R, Chai X, Marmorstein R, (2004) Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases. Proc Natl Acad Sci USA 101: 8563.
22. Chang JH, Kim HC, Hwang KY, Lee JW, Jackson SP, et al.(2002) Structural basis for the NAD-dependent deacetylase mechanism of Sir2. J Biol Chem 277: 34489-34498.
23. Finnin MS, Donigian JR, Pavletich NP, (2001) Structure of the histone deacetylase SIRT2. Nat Struct Biol 8: 621-5.
24. Min J, Landry J, Sternglanz R, Xu RM, (2001) Crystal structure of a SIR2 homolog-NAD complex. Cell 105: 269.
25. Avalos JL, Bever KM, Wolberger C, (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17: 855.
26. Zhao K, Chai X, Marmorstein R, (2004) Structure and Substrate Binding Properties of cobB, a Sir2 Homolog Protein Deacetylase from Escherichia coli. Journal of Molecular Biology 337: 731.
27. Costantini S, Facchiano AM, Colonna G, (2007) Evaluation of the structural quality of modeled proteins by using globularity criteria. BMC Structural Biology 7: 9.
28. Meszaros B, Simon I, Dosztanyi Z, (2009) Prediction of protein binding regions in disordered proteins. Plos Computational Biology 5: e1000376.
29. Paladino A, Costantini S, Colonna G, Facchiano AM, (2008) Molecular modelling of miraculin: structural analyses and functional hypotheses. Biochemical and Biophysical Research Communications 367: 26-32.
30. Cuff JA, Barton GJ, (2000) Application of enhanced multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins: Structure, Function and Genetics 40: 502-511.
31. Costantini S, Facchiano AM, (2009) Prediction of the protein structural class by specific peptide frequencies. Biochimie 91: 226-9.
32. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, et al.(2007) ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins 69: 781-5.
33. Liu S, Zhang C, Zhou H, Zhou Y, (2004) A physical reference state unifies the structure-derived potential of mean force for protein folding and binding. Proteins 56: 93-101.
34. Khan AN, Lewis PN, (2006) Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases. J Biol Chem 281: 11702-11.
35. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al.(2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
36. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT, (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. Journal of Molecular Biology 337: 635-645.
37. Bordoli L, Kiefer F, Schwede T, (2007) Assessment of disorder predictions in CASP7. Proteins 69S: 129-136.
38. Dyson HJ, Wright PE, (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6: 197-208.
39. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, et al.(2001) Intrinsically disordered protein. J Mol Graph Model 19: 26-59.
40. Tompa P, (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27: 527-533.
41. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, et al.(2007) Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J Proteome Res 6: 1882-1898.
42. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y, (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282: 6823-32.
43. Ford J, Ahmed S, Allison S, Jiang M, Milner J, (2008) JNK2-dependent regulation of SIRT1 protein stability Cell Cycle 19: 3091-3097.
44. Lamming DW, Wood JG, Sinclair DA, (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53: 1003-9.
45. Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, et al.(2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32: 1037.
46. Kim SY, Ferrell JE, (2007) Substrate competition as a source of ultrasensitivity in the inactivation of Wee1. Cell 128: 1133.
47. Thompson JD, Higgins DG, Gibson T, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
48. Sali A, Blundell TL, (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
49. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26: 283-291.
50. Kabsch W, Sander C, (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 2: 2577-2637.
51. Nishimasu H, Fushinobu S, Shoun H, Wakagi T, (2007) Crystal structures of an ATP-dependent hexokinase with broad substrate specificity from the hyperthermophilic archaeon Sulfolobus tokodaii. J Biol Chem 282: 9923-9931.
52. Dalton JAR, Jackson RM, (2007) An evaluation of automated homology modelling methods at low target-template sequence similarity. Bioinformatics 23: 1901-1908.
53. Altschul SF, Gish W, Miller W, Myers E, Lipman DJ, (1990) Best local alignment search tool. J Mol Biol 215: 403-410.
54. Shi J, Blundell TL, Mizuguchi K, (2001) FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 310: 243-257.
55. Karplus K, Karchin R, Draper J, Casper J, Mandel-Gutfreund Y, et al.(2003) Combining local-structure, fold-recognition, and new fold methods for protein structure prediction. Proteins 6: 491-6.
56. Xiang Z, Soto CS, Honig B, (2002) Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction. PNAS 99: 7432-7437.
57. Van Der Spoel D Lindahl E, Hess B, Groenhof G, Mark AE, et al.(2005) GROMACS: fast, flexible, and free. J Comput Chem 26: 1701-1718.
58. Costantini S, Colonna G, Facchiano AM, (2007) Simulation of conformational changes occurring when a protein interacts with its receptor. Computational Biology and Chemistry 31: 196-206.
59. Costantini S, Buonocore F, Facchiano AM, (2008) Molecular modelling of co-receptor CD8aa and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata). Fish Shellfish Immunology 25: 782-90.
60. Jones S, Thornton JM, (1996) Principals of protein-protein interactions derived from structural studies. PNAS 93: 13-20.